EFFECT OF TOPICAL NEPAFENAC VS TOPICAL DEXAMETHASONE ON CENTRAL MACULAR THICKNESS IN PATIENTS WITH DME

A prospective longitudinal study was conducted to compare the efficacy of Topical Nepafenac and Topical Dexamethasone on Central Macular Thickness in Patients with Diabetic Macular Edema. Total of 22 patients were enrolled in the study who attended the Outpatient Department and were randomly divided into two groups.Group A was administered Topical Nepafenac and Group B were administered Topical Dexamethasone over a period of 3 weeks.The study found that after 3 weeks that in both cases Central Macular Thickness decreased.Another finding was that the IOP rise in Group A was negligible but in Group B the IOP rise was significant.